ArticleCancer2025

Allogeneic transplantation provides added benefit to FMS-like tyrosine kinase 3 (FLT3) inhibitors for both low-intensity and high-intensity regimens in FLT3-mutated acute myeloid leukemia.

Pamela S BeckerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.